Fecal Microbiota Transplantation as a Therapeutic Strategy in the Progression of Chronic Kidney Disease

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 7, 2018

Primary Completion Date

November 7, 2019

Study Completion Date

April 21, 2020

Conditions
Chronic Kidney Disease Due to HypertensionChronic Kidney Disease Due to Type 2 Diabetes Mellitus
Interventions
BIOLOGICAL

Faecal microbiota transplant

Both groups will receive frozen capsules to be ingested orally (constituted of TMF or placebo according to the randomization) with a frequency of 15 capsules every 12hrs for 4 doses on days 1, 10 and 30 of the study. Each capsule should be ingested in a period no longer than 1 hour.

BIOLOGICAL

Placebo

Both groups will receive frozen capsules to be ingested orally (constituted of TMF or placebo according to the randomization) with a frequency of 15 capsules every 12hrs for 4 doses on days 1, 10 and 30 of the study. Each capsule should be ingested in a period no longer than 1 hour.

Trial Locations (1)

64460

Hospital Universitario José E. Gonzalez, Monterrey

All Listed Sponsors
lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER

NCT04361097 - Fecal Microbiota Transplantation as a Therapeutic Strategy in the Progression of Chronic Kidney Disease | Biotech Hunter | Biotech Hunter